Third Party Evaluation Clause Samples
POPULAR SAMPLE Copied 5 times
Third Party Evaluation. According to District procurement procedures, the District and Association shall jointly charge an independent, third party evaluation of the Professional Compensation System for Teachers. This evaluation shall examine the implementation of the system and its effectiveness at achieving District and Association mission and goals and in keeping with the terms and conditions of this Agreement, the ballot language approved by the voters in the mill levy override election, and the goals and elements of the Professional Compensation System for Teachers. This evaluation shall offer findings and recommendations for improvement of the system. This evaluation shall be presented to the Board of Education, the DCTA Board of Directors and the Trust Board in November 2009, prior to when the District and Association commence negotiations on the Professional Compensation System for Teachers, thus ensuring that those negotiations shall be supported by data.
4.3.2.1 The Transition Team of the Professional Compensation System for Teachers shall recommend the evaluator to the District and Association no later than April of 2008.
4.3.2.2 The Department of Human Resources shall develop measures of performance of the elements of the Professional Compensation System for Teachers to be used in their evaluation. The Transition Team will review these measures and, once approved, recommend them to the evaluator.
4.3.2.3 The District and the Association shall collaborate to develop external funding for the independent, third party evaluation of the Professional Compensation System for Teachers. If external funding is not developed then alternative methods, including the use of mill levy revenue, may be used to obtain the third party evaluation.
Third Party Evaluation. During the Option Period, Omeros shall have the right to engage one or more third parties (each a “Third Party”) to conduct testing of the MOCA Technology in accordance with the Plan for MOCA Evaluation on Omeros’ behalf and at Omeros’ expense, provided that Omeros shall (a) disclose to Patobios the identity of each Third Party and what portion(s) of the Plan for MOCA Evaluation each Third Party is conducting on behalf of Omeros and (b) enter into a written agreement with each Third Party pursuant to which such Third Party shall agree that any Improvements made by such Third Party shall be initially owned solely by Patobios and that any written study reports to be prepared by such Third Party at the end of each defined evaluation or test phase of any study being performed as part of the Plan for MOCA Evaluation shall be provided contemporaneously to Patobios and Omeros. Omeros shall not use a Third Party to conduct testing of the MOCA Technology until Patobios shall have been given the opportunity to review and approve those portions of Omeros’ agreement with the Third Party that are intended to comply with Omeros’ obligations pursuant to this Section 3.1(b), provided that Patobios shall not unreasonably withhold or delay its review and approval of those portions of such agreement.
Third Party Evaluation. As part of the process described in Section 4.2.2(b), or if the Parties cannot otherwise agree on the compensation payable to Salix by Alfa for, and other terms of, the Salix Designated Indication License, the Parties shall engage [*], or another independent Third Party mutually agreed by both Alfa and Salix, to provide an evaluation of the market potential of the Salix Designated Indication Product, and an estimate or range of potential licensing terms by applying the Valuation Principles. The Parties shall share the fees and expenses of any Third Party providing an evaluation and other services pursuant to this Section 4.2.2 equally.
Third Party Evaluation. If the dispute is not resolved within 45 (forty-five) Business Days, a sample of the non-conforming Batch and another sample that both Parties stipulate is conforming will be evaluated against the Specifications by a mutually agreeable Third Party laboratory whose results shall be final and binding on the Parties. The cost of this evaluation shall be borne by the Party whose position on conformity was controverted by the Third Party evaluation, provided that, if the non-conformity was due to a defect in materials provided by or on behalf of AMICUS (e.g., defective cell lines) not reasonably ascertainable by WUXI BIOLOGICS in advance, then AMICUS shall pay for the evaluation and the non-conforming Batch. The Parties hereby designate [***] to be the Third Party laboratory since they have validated the analytical methods for API and Product.
Third Party Evaluation. If requested by either Party, both Parties agree to cooperate on any reasonable requests related to a third-party study of the effectiveness of the Programs. LIS shall bear the entire financial cost of the study. Upon request, LIS shall identify the vendor and submit it to RSD for their approval. Upon completion, both Parties agree to review the results collaboratively.